New to Bybit? Register and trade to claim $20 NVDAX! That’s not all — new users can unlock up to $100 welcome gifts. One Bybit, Trade All. Easy like a game 🔥 #Bybit #NewFinancialPlatform
The benchmark index rose on broad-based buying, marking its strongest daily performance in over two weeks. Indonesia’s IDX Composite Index climbed 1.19% to close at a two-week high, led by gains across financials, consumer staples, and energy sectors. The advance followed
Investors react positively to reports of progress in U.S.-Iran negotiations, lifting regional market sentiment. European equities climbed in early trading as optimism over a potential U.S.-Iran peace deal reduced geopolitical risk. Major indices in Germany, France, and the
BPIFrance's placement of 6.5 million Technip Energies shares weighs on the stock, diluting ownership by 5.6%. Technip Energies shares fell after BPIFrance placed 6.5 million shares, representing 5.6% of the company’s capital. The sale, conducted at €14.50 per share, was ex
Analysts cite positive clinical trial progress as the key driver for reiterating the stock's bullish outlook. Guggenheim reaffirmed its Buy rating on EyePoint Pharmaceuticals (EYPT) following recent advancements in the company’s clinical trials. The firm highlighted progre
Stifel reaffirms its bullish stance on Elanco Animal Health with a $32 target amid ongoing market analysis. Stifel reiterated its Buy rating on Elanco Animal Health (ELAN) and set a $32 price target for the stock. The decision reflects continued confidence in the company’s
Henkel Co KGaA AG reports stronger Q1 2026 results driven by strategic acquisitions, lifting investor confidence. Henkel Co KGaA AG shares rose following its Q1 2026 earnings call, as strategic acquisitions bolstered financial performance. The company highlighted improved
The brokerage cites reduced visibility into QDEL earnings as the reason for lowering its rating on the diagnostics firm. Jefferies lowered its rating on QuidelOrtho (QDEL) to hold from buy, citing concerns over earnings visibility. The downgrade reflects uncertainty around
The Danish hearing-aid maker reduced its 2026 revenue forecast following weaker-than-expected first-quarter sales. GN Store Nord shares fell 6% after reporting first-quarter revenue below analyst estimates. The company cited softer demand in key markets and supply chain di
A group of SpaceX investors seeks regulatory scrutiny of the proposed IPO structure, citing concerns over Elon Musk's unchecked authority. A coalition of SpaceX investors has urged the SEC to examine the company's planned IPO structure, arguing it grants Elon Musk dispropo
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.